TIAA CREF Investment Management LLC Raises Stake in Illumina, Inc. (ILMN)

TIAA CREF Investment Management LLC lifted its holdings in shares of Illumina, Inc. (NASDAQ:ILMN) by 55.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,475,669 shares of the life sciences company’s stock after purchasing an additional 527,548 shares during the quarter. TIAA CREF Investment Management LLC owned about 1.01% of Illumina worth $256,058,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. Penserra Capital Management LLC lifted its position in shares of Illumina by 13.0% during the second quarter. Penserra Capital Management LLC now owns 884 shares of the life sciences company’s stock worth $153,000 after purchasing an additional 102 shares in the last quarter. Paradigm Asset Management Co. LLC lifted its position in shares of Illumina by 5.6% during the second quarter. Paradigm Asset Management Co. LLC now owns 950 shares of the life sciences company’s stock worth $165,000 after purchasing an additional 50 shares in the last quarter. Patten Group Inc. lifted its position in shares of Illumina by 2.7% during the first quarter. Patten Group Inc. now owns 965 shares of the life sciences company’s stock worth $166,000 after purchasing an additional 25 shares in the last quarter. NN Investment Partners Holdings N.V. lifted its position in shares of Illumina by 11.3% during the second quarter. NN Investment Partners Holdings N.V. now owns 985 shares of the life sciences company’s stock worth $171,000 after purchasing an additional 100 shares in the last quarter. Finally, Bronfman E.L. Rothschild L.P. lifted its position in shares of Illumina by 3.6% during the first quarter. Bronfman E.L. Rothschild L.P. now owns 1,198 shares of the life sciences company’s stock worth $204,000 after purchasing an additional 42 shares in the last quarter. 93.34% of the stock is currently owned by institutional investors and hedge funds.

In related news, SVP Charles Dadswell sold 145 shares of the company’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $174.24, for a total transaction of $25,264.80. Following the sale, the senior vice president now directly owns 10,646 shares of the company’s stock, valued at approximately $1,854,959.04. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Omead Ostadan sold 1,672 shares of the company’s stock in a transaction that occurred on Friday, July 7th. The shares were sold at an average price of $172.73, for a total value of $288,804.56. Following the sale, the executive vice president now directly owns 26,242 shares in the company, valued at $4,532,780.66. The disclosure for this sale can be found here. Over the last three months, insiders have sold 165,705 shares of company stock worth $31,202,418. Corporate insiders own 1.60% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “TIAA CREF Investment Management LLC Raises Stake in Illumina, Inc. (ILMN)” was first posted by Markets Daily and is owned by of Markets Daily. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright law. The legal version of this article can be read at https://www.themarketsdaily.com/2017/09/12/tiaa-cref-investment-management-llc-raises-stake-in-illumina-inc-ilmn.html.

ILMN has been the topic of several analyst reports. Leerink Swann raised shares of Illumina to an “outperform” rating and raised their target price for the company from $207.00 to $225.00 in a report on Tuesday. Vetr raised shares of Illumina from a “buy” rating to a “strong-buy” rating and set a $197.84 target price on the stock in a report on Tuesday, May 23rd. Morgan Stanley reaffirmed an “underweight” rating and issued a $115.00 target price (up previously from $108.00) on shares of Illumina in a report on Monday, May 15th. First Analysis raised shares of Illumina from an “underweight” rating to an “equal weight” rating and set a $176.00 target price on the stock in a report on Wednesday, August 2nd. Finally, Zacks Investment Research cut shares of Illumina from a “buy” rating to a “hold” rating in a report on Friday, August 4th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and ten have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $178.51.

Shares of Illumina, Inc. (ILMN) traded down 0.25% during trading on Tuesday, hitting $211.72. 395,583 shares of the stock were exchanged. The stock has a market cap of $30.91 billion, a PE ratio of 42.48 and a beta of 0.81. The stock’s 50 day moving average price is $193.03 and its 200 day moving average price is $179.01. Illumina, Inc. has a one year low of $119.37 and a one year high of $213.59.

Illumina (NASDAQ:ILMN) last posted its quarterly earnings results on Tuesday, August 1st. The life sciences company reported $0.82 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.14. The business had revenue of $662.00 million for the quarter, compared to analyst estimates of $642.38 million. Illumina had a return on equity of 19.69% and a net margin of 30.27%. The business’s revenue was up 10.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.86 EPS. Equities research analysts predict that Illumina, Inc. will post $3.65 EPS for the current year.

Illumina Company Profile

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Want to see what other hedge funds are holding ILMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Illumina, Inc. (NASDAQ:ILMN).

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply